Members of the public, clinicians, healthcare providers, and industry innovators are being invited to share their views on how artificial intelligence should be regulated in healthcare as part of a new Call for Evidence launched today by the Medicines and Healthcare products Regulatory Agency.
The call will directly support the work of the newly established National Commission into the Regulation of AI in Healthcare, which brings together global AI leaders, clinicians, regulators, and patient advocates. The Commission will advise the MHRA on how health AI should be governed in the years ahead.
The MHRA’s initiative is described as a vital opportunity for everyone – including patients, health professionals, developers, and members of the public – to help shape a new generation of standards and safeguards for AI technologies used within the NHS and wider healthcare system.
The MHRA is particularly keen to hear from contributors with a range of experiences, whether they work closely with AI tools or simply have views on what rules and protections are needed to ensure safe, fair, and effective use.
Input gathered through the call for evidence will help the MHRA regulate emerging AI technologies so that they meet the needs of patients and families, work safely within the NHS, and support responsible innovation across the health sector.
Lawrence Tallon, MHRA Chief Executive, commented:
“AI is already revolutionising our lives, both its possibilities and its capabilities are ever-expanding, and as we continue into this new world, we must ensure that its use in healthcare is safe, risk-proportionate and engenders public trust and confidence.
“The National Commission brings together a host of experts including patients’ groups, clinicians, industry, academics, and members from across government. Today we are asking the public to contribute by sharing their thoughts, experiences, and opinions.
“We want everyone to have the chance to help shape the safest and most advanced AI-enabled healthcare system in the world at this truly pivotal moment.”
The Commission is asking for views on several important areas:
- Modernising AI rules in healthcare: Do current regulations work, or do they need updating to keep pace with rapidly developing technologies?
- Keeping patients safe as AI evolves: How can regulators monitor advanced AI systems that learn and adapt over time, and identify problems early?
- Clarifying responsibility: What is the right balance of responsibility between regulators, technology companies, healthcare providers, and individuals?
The information collected will help inform the Commission’s recommendations to the MHRA in 2026 and ensure the UK develops a robust regulatory system that keeps patients safe while enabling innovation to flourish.
Image credit: iStock
